Zymeworks Inc. is a privately held biotechnology company based in Vancouver, British Columbia. Zymeworks is committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases.

Zymeworks’ approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. Using this approach Zymeworks has developed multiple platform technologies to advance the field of biologics drug discovery and optimization.


Date Type Amount Investors Valuation
09/01/11 Other 8.1M CTI Life Sciences Fund, Advanced Biotechnologies Venture Fund Unknown
09/01/12 Other 11M Advanced Biotechnologies Venture Fund Unknown